MiT family translocation carcinomas
Revision as of 13:53, 3 August 2016 by Snewman (talk | contribs) (Created page with "Category:Diseases Category:Recently Added Pages Category:Kidney __TOC__ == Contributors == == Tumor Type == == Tumor Classification == == Description == == I...")
Contributors
Tumor Type
Tumor Classification
Description
IHC Markers
Genomic Gain/Loss/LOH
| Chromosome | Gain/Loss/Amp | Region |
|---|---|---|
| 1 | Loss | Chr1 |
| 2 | Loss | Chr14 |
| 3 | Loss | Chr21 |
| 4 | Loss | ChrX |
| 5 | Loss | ChrY (male) |
Rearrangements
Mutations (SNV/INDEL)
From Cosmic Mutated in >20%
Mutated in 10-20%
Mutated in 5-10%
Mutated in 2-5%
mtDNA
Epigenomics (methylation)
Main Pathways Involved
Diagnosis
Prognosis
Therapeutics
Write your comments here